![CKD Bio Corp. logo](/logos/063160.KS.webp)
CKD Bio Corp.
KRX:063160.KS
Overview | Financials
Company Name | CKD Bio Corp. |
Symbol | 063160.KS |
Currency | KRW |
Price | 29,800 |
Market Cap | 163,481,518,600 |
Dividend Yield | 0% |
52-week-range | 19,050 - 35,700 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jang-Han Lee |
Website | https://www.ckdbio.com |
An error occurred while fetching data.
About CKD Bio Corp.
CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD